Updated COVID-19 Vaccines to Include Children Ages 6 Mos – 5 Yrs.

Translate to Spanish or other 102 languages!

CDC expanded the use of updated (bivalent) COVID-19 vaccines for children ages 6 months through 5 years. mage for illustration purposes
CDC expanded the use of updated (bivalent) COVID-19 vaccines for children ages 6 months through 5 years. mage for illustration purposes

Mega Doctor News

- Advertisement -

CDC expanded the use of updated (bivalent) COVID-19 vaccines for children ages 6 months through 5 years. Children ages 6 months through 5 years who previously completed a Moderna primary series are eligible to receive a Moderna bivalent booster 2 months after their final primary series dose. Children ages 6 months through 4 years who are currently completing a Pfizer primary series will receive a Pfizer bivalent vaccine as their third primary dose.

Updated COVID-19 vaccines are formulated to protect against some of the more recently circulating viruses.

Most importantly, COVID-19 vaccines are critical to providing ongoing protection as immunity wanes and the virus continues to mutate.

- Advertisement -

The vast majority of children in this age group have not received any doses of a COVID-19 vaccine. CDC is working to increase parent and provider confidence in COVID-19 vaccines and improve uptake among the 95% of children who are not vaccinated or who have not completed the COVID-19 vaccine primary series. Parents should talk to their child’s health care provider to ensure their child is up to date on their COVID-19 and other vaccines.

Information Source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

The Impact of Physical Activity on Parkinson’s Decline

For 68-year-old Robert Kennedy, a retired Florida Power and Light foreman, the secret to managing his Parkinson symptoms is movement.

FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment 

The U.S. Food and Drug Administration approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.

Why Strength Training Is Your Best Defense Against Osteoporosis

Reports show women are at higher risk for developing the bone weakening condition as they get older.

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.
- Advertisement -